Results

Total Results: 1,541 records

Showing results for "months".

1501. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
      August 01, 2016 - Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings B A C K G R O U N D Alcohol use disorder (AUD) includes harmful use of alcohol, alcohol abuse, and alcohol dependence. In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), alcohol abuse and alcohol de…

1502. Treating Binge-Eating Disorder. A Review of Evidence for Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_consumer.pdf
      May 01, 2016 - People with BED binge eat at least once a week for at least 3 months.

1503. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
      July 06, 2015 - a randomized controlled trial (RCT) or 1000 (observational study) patients, or was not at least 6 months … did not enroll at least 75 patients (RCT) or 1000 patients (observational study), was not at least 6 months … Following a median followup of 56 months, the ARB telmisartan was relatively well tolerated, with only … with Perindopril in stable coronary Artery disease), included patients who were at least 3 to 6 months … Following a median followup of 56 months, the ARB telmisartan was relatively well tolerated, with only

1504. ADHD-Update-protocol-160818 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
      August 18, 2016 - Furthermore, symptoms need to be present for at least 6 months, occur in at least 2 different settings … • Timing: o To assess diagnostic accuracy, diagnostic follow-up must be within 4 months of the … 2 Timing KQ 1: • For assessment of diagnostic accuracy: diagnostic follow-up must be within 4 months … Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to … The disposition of comments for systematic reviews and technical briefs will be published three months

1505. Gout Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
      March 01, 2016 - the same pharmaceutical interventions increase the risk of acute gout attacks in the short term (months … finding that urate lowering therapy does not reduce the risk of acute gout attacks in the first 6 months … Some evidence indicates that allopurinol reactions are more likely to occur in the first six months … fact that this outcome has not been studied in any placebo-controlled trial of longer than a few months … the one RCT of urate lowering therapy where prophylactic colchicine or NSAIDs were continued for 6 months

1506. RESPONSE TO REQUEST FOR WORK ASSIGNMENT (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
      December 01, 2009 - exacerbation that resulted in a hospitalization or at least two outpatient exacerbations in the last 12 months … Covariates We defined covariates from the 12 months preceding the index date. … baseline and had a slightly larger percentage with 3 or more outpatient visits in the preceding 12 months

1507. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
      March 21, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … for this review includes nonpregnant women from menarche to menopause who have had AUB for three months … complaints of chronic irregular uterine bleeding (problem bleeding [frequent or infrequent] of 3 months … defects, and related systemic disease) or abnormal cyclic uterine bleeding (Problem bleeding of 3 months

1508. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
      February 01, 2017 - fractionation Overall pain relief with retreatment (%) 34% 8 Gy in 1 fx 20 Gy in 5 fx 45 51 at 2 months … at 24 mo Nilsson, 201318 64, prostate EBRT plus 223Ra EBRT plus placebo NR NR NR NR 30% 13% at 24 months

1509. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
      December 01, 2012 - survival time from diagnosis of liver metastases and reported median survival times of 27 and 26.3 months … survival from time of study treatment.69,80,86 Two studies reported median survival of 25 and 17 months … intervention and both defined survival from time of study treatment.81,90 Median survival was 9.7 months … and 6.7 months (95% CI, 5 to 8.3 months). 14 Table D. … One study reported a median survival of 11.8 months.65 The other study reported a 1-year survival of

1510. Heart-Failure-Natriuretic-Peptide Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
      November 01, 2013 - Generally, studies predicting short-term mortality (up to 31 days) and longer term mortality (24 months … Most studies evaluated medium-range time intervals (6 to 12 months), and they consistently showed that … Far fewer studies evaluated longer term prognosis (>12 months), and these studies measured admission … This conclusion applies across all periods of followup, from 12 months to 44 months. … studies of both decompensated HF (from 31 days to 6.8 years) and chronic stable HF (from 12 to 37 months

1511. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
      September 29, 2014 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Indeed, the authors of the present systematic review themselves defined “chronic opioid use” as 3 months … However, we identified no placebo- controlled trials of opioid therapy for at least 6 months. … Especially in the case of fatal overdose, excluding studies based on duration of therapy < 3 months … The study you mention was excluded because the duration was only 6 months.

1512. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
      February 01, 2012 - Short-term is defined as outcomes occurring within 6 months; long-term is defined as outcomes occurring … after 6 months … research are based on the limitations of the current evidence: • Studies examining long-term (at least 6 months

1513. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
      May 14, 2010 - • Timing: - Minimum duration of follow-up will be 12 months. … Update searches will be conducted 6 months after the start date of the project and during the review … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

1514. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
      September 01, 2011 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Specifically, this more comprehensive report describes the clinical outcome during six months of follow … Long-term durability of effect was then examined over the subsequent six months. … 10%; Kaplan- Meier survival estimate = 12.9%) met protocol-specified relapse criteria during the 6 months … The study analyzes outcome measures after 3, 12, and 24 months of vagal nerve stimulation George

1515. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
      October 01, 2015 - ; 9 trials; RR, 0.58; 95% CI, 0.36 to 0.94, I2 = 75%), intermediate-term (3 months to <1 year; 5 trials … • Narrow band imaging was associated with lower risk of bladder cancer recurrence at 3 months (3.9% … vs. 17%; odds ratio [OR], 0.62; 95% CI, 0.41 to 0.92) and at 12 months (OR, 0.24; 95% CI, 0.07 to … ; 9 trials;RR, 0.58; 95% CI, 0.36 to 0.94; I2=75%), intermediate-term (3 months to <1 year; 5 trials … (3.9% vs. 17%; OR, 0.62; 95% CI, 0.41 to 0.92) and at 12 months (OR, 0.24; 95% CI, 0.07 to 0.81) in

1516. Disposition of Comments for Child Exposure to Trauma: Comparative Effectiveness of Interventions Addressing Maltreatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_disposition-comments.pdf
      April 15, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … report, under Study Design and Duration, it states that the post intervention timeframe was “11 to 13 months … The post intervention timepoint was actually immediately following the intervention, or 11-13 months … page E-41 of the Appendix, under Study Duration, it states that the intervention lasted for 11-13 months … available for this report (these products are typically ready for posting on the AHRQ website 3-6 months

1517. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
      January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding six months … declaration from the importer stating that the worms are for personal use and constitute 3 or fewer months … interim analysis of patients with SBS (n = 34) treated with either teduglutide or placebo for 12 months … Additionally, after 12 months of treatment with teduglutide, 53% of patients reduced their infusion

1518. Arthritis-Knee-Physical-Therapy Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
      November 01, 2012 - Most studies lasted 4 to 6 weeks, with a followup of 6 months. … Within 3 months, aerobic exercise improved composite function and gait function. … through more than 12 months followup. … Function did not improve further at 6 months followup. Proprioception Exercises. … However, pain worsened at 6 months.

1519. Infectious Disease Including HIV/AIDS #09 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
      January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding 6 months … and 12 months compared with usual care. … but not 12 months. … The median time of illness before therapy was 11 months, and the mean number of courses of antibiotic … Two experienced a recurrence 5 to 12 months after receiving subsequent antibiotic treatment and were

1520. Binge-Eating Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
      December 01, 2015 - Effective Health Care to once per week and the duration criterion from 6 months to 3 months, in line … At least 2 days a week for 6 months (DSM-IV frequency and duration criteria) b. … At least 1 day a week for 3 months (DSM-5 frequency and duration criteria) Criterion 5 The binge eating … This disposition report will be made available 3 months after AHRQ posts the final review on its Web … Comprehensive interview assessment of eating behavior 18-35 months after gastric bypass surgery for